AgeX Therapeutics, Inc. appointed Gregory Bailey, M.D., as Chairman of the Board, Dr. Annalisa Jenkins, to the Board. Dr. Jenkins previously served as President and CEO of Dimension Therapeutics, a leading gene therapy company, and had prior global R&D leadership roles at Merck Serono and Bristol Myers-Squibb. Appointed John F. Mauldin to the Board. Mr. Mauldin appears regularly on CNBC, Yahoo Tech Ticker, and Bloomberg TV. Mr. Mauldin serves as Chairman of Mauldin Economics, an investment newsletter and information publishing firm. Appointed Dr. Nafees Malik, a specialist in the strategy, execution and commercialization of cell therapies as Chief Operating Officer. Dr. Malik also serves as the Head of Cellular Therapy at Juvenescence. His prior roles have spanned clinical medicine, healthcare investment banking and biopharmaceutical companies.